Skip to main content

Rare Cancers

FDA Grants Approval to Avapritinib for Patients with GIST
FDA News & Updates, Gastrointestinal Cancers, In the News, Rare Cancers, FDA Approvals
Web Exclusives
The FDA approval of avapritinib marks the first time a drug has been approved specifically for patients with GIST harboring PDGFRA exon 18 mutations, which are involved in approximately 10% of GIST cases. Read More ›
Promising Vaccine Combination Identified for Patients With Metastatic Pancreatic Cancer
By Wayne Kuznar
Rare Cancers
TOP - May 2014, Vol 7, No 2
A dual vaccine strategy improved survival more than single vaccination of patients with metastatic pancreatic ductal adenocarcinoma (PDAC). Data from a randomized phase 2 trial were reported by Dung T. Le, MD, at the 2014 Gastrointestinal Cancers Symposium. Read More ›
Advances in the Treatment of Pancreatic Neuroendocrine Tumors
By Caroline Helwick
Rare Cancers
December 2012, Vol 5, No 8
Interest in pancreatic neuroendocrine tumors (pNETs) has grown since the recent approval of targeted agents for advanced disease, as was evident by the attendance at several sessions during the European Society for Medical Oncology (ESMO) 2012 Congress in Vienna, Austria.1 Read More ›